Salvianolic acid A inhibits tumor-associated angiogenesis by blocking GRP78 secretion.
Angiogenesis
Exosome
Interaction
Salvianolic acid A
Tumor-secreted GRP78
Journal
Naunyn-Schmiedeberg's archives of pharmacology
ISSN: 1432-1912
Titre abrégé: Naunyn Schmiedebergs Arch Pharmacol
Pays: Germany
ID NLM: 0326264
Informations de publication
Date de publication:
04 2019
04 2019
Historique:
received:
31
07
2018
accepted:
12
11
2018
pubmed:
19
12
2018
medline:
25
4
2020
entrez:
19
12
2018
Statut:
ppublish
Résumé
Glucose-regulated protein 78 (GRP78) often highly expresses in a wide range of tumors, which plays promotive functions due to its diversity of location in the development of tumor. Particularly, GRP78 can be secreted into microenvironment by tumor cells through the pathway of exosome, which promotes proliferation, angiogenesis, and drug resistance in cancer cells. Hence, we discovered a potential inhibitor to block GRP78 secretion. We screened five small molecules that may interact with the GRP78 from 51 traditional Chinese medicine molecules by molecular docking. By using western blot, we found that one of the molecules can inhibit the secretion of GRP78, which is salvianolic acid A (SAA). Further, SAA could interact with the lysine residue 633 (K633) of GRP78, which inhibited GRP78 secretion. Moreover, SAA-GRP78 interaction can facilitate GRP78 of cytosol sorted into lysosome for degradation rather than exosome. In conclusion, our research revealed that SAA has the novel function of anti-angiogenesis via the tumor environment.
Identifiants
pubmed: 30560355
doi: 10.1007/s00210-018-1585-2
pii: 10.1007/s00210-018-1585-2
doi:
Substances chimiques
Angiogenesis Inhibitors
0
Caffeic Acids
0
Endoplasmic Reticulum Chaperone BiP
0
HSPA5 protein, human
0
Heat-Shock Proteins
0
Hspa5 protein, mouse
0
Lactates
0
salvianolic acid A
51622542XO
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
467-480Références
Int J Biochem Cell Biol. 2013 May;45(5):987-94
pubmed: 23485528
Asian Pac J Cancer Prev. 2014;15(17):7245-9
pubmed: 25227822
Cold Spring Harb Perspect Med. 2012 Dec 01;2(12):a006676
pubmed: 23209177
J Control Release. 2017 Jun 10;255:120-131
pubmed: 28344016
Biochem Biophys Res Commun. 2013 Nov 1;440(4):558-63
pubmed: 24113381
Cell Death Dis. 2014 May 22;5:e1240
pubmed: 24853418
J Cell Mol Med. 2016 Mar;20(3):389-402
pubmed: 26648178
Anticancer Drugs. 2015 Feb;26(2):210-23
pubmed: 25419632
Oncogene. 2016 Mar 24;35(12):1517-28
pubmed: 26119938
Int J Mol Sci. 2016 Aug 02;17(8):
pubmed: 27490540
Cancer Res. 2007 Apr 15;67(8):3496-9
pubmed: 17440054
J Cardiovasc Pharmacol. 2011 Nov;58(5):535-42
pubmed: 21795988
Cell Biochem Biophys. 2011 Jun;60(1-2):39-46
pubmed: 21448666
J Genet Syndr Gene Ther. 2013 Mar 11;4(2):
pubmed: 23750325
Biomed Res Int. 2014;2014:179486
pubmed: 24963475
Trends Cell Biol. 2014 Jan;24(1):19-25
pubmed: 24287454
Semin Cancer Biol. 2013 Dec;23(6 Pt B):522-32
pubmed: 24012661
J Ethnopharmacol. 2014;151(1):218-27
pubmed: 24189032
Cancer Res. 2008 Jan 15;68(2):498-505
pubmed: 18199545
Biochem Cell Biol. 2000;78(3):181-91
pubmed: 10949073
Biochem J. 2011 Mar 1;434(2):181-8
pubmed: 21309747
J Vis Exp. 2015 Jan 17;(95):50974
pubmed: 25650897
Int J Nanomedicine. 2014 Dec 30;10:245-56
pubmed: 25565817
Oncotarget. 2016 Jun 28;7(26):40800-40815
pubmed: 27027348
Cell Death Differ. 2014 May;21(5):797-810
pubmed: 24464222
Am J Pathol. 2001 Mar;158(3):1145-60
pubmed: 11238063
Cancer Biol Ther. 2015;16(9):1407-14
pubmed: 26176734
Pharmacol Ther. 2016 Jun;162:58-68
pubmed: 26969215
Cell Mol Life Sci. 2018 Jan;75(2):193-208
pubmed: 28733901
Anticancer Res. 2015 Nov;35(11):5773-88
pubmed: 26503998
Blood. 2009 Oct 29;114(18):3960-7
pubmed: 19713465
Prog Biophys Mol Biol. 2013 Nov;113(2):333-54
pubmed: 24139944
Cancer Res. 2011 Apr 15;71(8):2848-57
pubmed: 21467168
Semin Immunopathol. 2011 Sep;33(5):441-54
pubmed: 21688197
Fitoterapia. 2016 Dec;115:74-85
pubmed: 27693342
Mol Cell Endocrinol. 2018 Oct 15;474:57-64
pubmed: 29474877
Nat Med. 2012 Jun;18(6):883-91
pubmed: 22635005
Sci Rep. 2016 Jul 27;6:30406
pubmed: 27460191
Mol Biol Cell. 2006 Dec;17(12):5038-52
pubmed: 17005911
Front Biosci (Schol Ed). 2011 Jan 01;3:216-25
pubmed: 21196371
Oncotarget. 2018 Jan 09;9(21):15464-15479
pubmed: 29643986
J Biomed Sci. 2011 May 11;18:30
pubmed: 21569331
Cancer Sci. 2016 Apr;107(4):385-90
pubmed: 26797692
Oncotarget. 2017 Mar 21;8(12):19354-19364
pubmed: 28423613
J Clin Pharmacol. 2005 Dec;45(12):1345-59
pubmed: 16291709